Annual report pursuant to Section 13 and 15(d)

Income Taxes

v3.7.0.1
Income Taxes
12 Months Ended
Jun. 30, 2017
Income Tax Disclosure [Abstract]  
Income Taxes

NOTE 7 – INCOME TAXES  

 

The Company follows ASC 740-10-10, under which an entity recognizes deferred tax assets and liabilities for future tax consequences or for events that were previously recognized in the Company’s financial statements or tax returns. The measurement of deferred tax assets and liabilities is based on enacted tax law provisions. The effects of future changes in tax laws or rates are not anticipated. Through June 30, 2010, the Company operated exclusively in Australia. The Company was wholly subject to Australian income tax laws and regulations, which are administered by the Australian Taxation Office for the years ended June 30, 2010 and all prior years. 

 

On November 23, 2010, Propanc Health Group Corporation was incorporated in the state of Delaware. In January 2011, Propanc Health Group Corporation acquired all of the outstanding shares of Propanc PTY LTD on a one-for-one basis making it a wholly-owned subsidiary. As a result of these transactions, the Company is subject to the income tax laws of both the United States and Australia for the years ended June 30, 2012 through June 30, 2017.  

 

For the years ended June 30, 2017 and 2016, the Company’s losses before income taxes resulted from both its Australian and US activities and its taxable losses are subject to both Australian and U.S. tax law. At June 30, 2017, the Company has net operating loss carryforwards (NOL) for Australian tax purposes only that approximates $13,809,000. At June 30, 2017, the Company has NOL carryforwards for US tax purposes only that approximates $2,922,000. Consequently, the Company may have NOL carryforwards available for income tax purposes that will continue to be available until they are recovered through earning taxable income.  Deferred tax assets would arise from the recognition of anticipated utilization of these net operating losses to offset future taxable income. The NOL for Australian tax purposes is subject to a reduction of $3,368,287 for research and development credits granted by the Australian Taxation Office through June 30, 2017. 

 

The components for the provision for income taxes are as follows:

 

    Year Ended  
    June 30,     June 30,  
    2017     2016  
             
Current Taxes   $ (305,673 )   $ (72,538 )
Deferred Taxes     -       -  
Income Taxes Expense (Benefit)   $ (305,673 )   $ (72,538 )

  

The items accounting for the difference between income taxes at the Australia statutory rate and the provision for income taxes are as follows:

 

    Year Ended  
    June 30,     June 30,  
    2017     2016  
    Amount     Impact on
Rate
    Amount     Impact on
Rate
 
                         
Income Tax Expense (Benefit) at Australia Statutory Rate   $ (1,830,192 )     (22.39 )%   $ (2,190,750 )     (23.10 )%
                                 
Expenses Paid by Parent on Behalf of Foreign Subsidiary     922,125       11.28 %     1,113,419       11.74 %
                                 
R&D Refundable Tax Credit     (305,673 )     (3.74 )%     (72,538 )     (0.76 )%
                                 
Reduction of NOL Carryforward Due to R&D Tax Credit     305,673       3.74 %     72,538       0.76 %
                                 
Change in Deferred Tax Valuation Allowance     881,596       10.79 %     900,761       9.50 %
                                 
Foreign Exchange Rate Changes     (279,202 )     (3.42 )%     104,032       1.10 %
                                 
Total Income Tax Expense (Benefit)   $ (305,673 )     (3.74 )%   $ (72,538 )     (0.76 )%

 

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and amounts used for income tax purposes. Significant components of the Company's net deferred income taxes are as follows:

 

    June 30,     June 30,  
    2017     2016  
Current Deferred Tax Assets                
Warrant Derivative Liability   $ 8,460     $ 23,818  
Provision for Annual Leave     36,190       27,966  
Superannuation     99       -  
Total Current Deferred Tax Assets   $ 44,749     $ 51,784  
                 
Current Deferred Tax Liabilities                
Prepaid Investor Services   $ 16,966     $ 6,198  
Total Current Deferred Tax Liabilities   $ 16,966     $ 6,198  
                 
Non-Current Deferred Tax Assets                
Prepaid Investor Services   $ 426,664     $ 378,409  
Capital Raising Costs     23,325       22,489  
Legal Costs     23,648       22,801  
Intellectual Property     11,643       11,226  
Patent Costs     128,950       91,408  
Formation Expense     6,881       6,881  
Net Operating Loss Carryover     4,215,141       4,155,936  
Foreign Exchange Loss (OCI)     (39,379 )     (39,379 )
Total Non-Current Deferred Tax Assets     4,796,873       4,649,771  
Deferred Tax Valuation Allowance     (4,858,588 )     (4,707,753
Total Non-Current Deferred Tax Assets     (61,715 )     (57,982 )
                 
Total Deferred Tax Assets (Net)   $ -     $ -  

 

Management has determined that the realization of the net deferred tax asset is not assured and has created a valuation allowance for the entire amount of such benefits. 

 

The Company follows ASC 740-10, which provides guidance for the recognition and measurement of certain tax positions in an enterprise’s financial statements.  Recognition involves a determination whether it is more likely than not that a tax position will be sustained upon examination with the presumption that the tax position will be examined by the appropriate taxing authority having full knowledge of all relevant information.

 

The Company’s policy is to record interest and penalties associated with unrecognized tax benefits as additional income taxes in the statement of operations. As of June 30, 2017 the Company had no unrecognized tax benefits. There were no changes in the Company’s unrecognized tax benefits during the years ended June 30, 2017 and 2016. The Company did not recognize any interest or penalties during fiscal 2017 or 2016 related to unrecognized tax benefits.

 

The income tax returns filed for the tax years from inception will be subject to examination by the relevant taxing authorities.